124 related articles for article (PubMed ID: 19763440)
1. Lipid generation and signaling in ovarian cancer.
Xu Y; Wang D; Wang Z
Cancer Treat Res; 2009; 149():241-67. PubMed ID: 19763440
[No Abstract] [Full Text] [Related]
2. Lysophosphatidic acid and invasion.
Wang F; Fishman DA
Cancer Treat Res; 2009; 149():269-96. PubMed ID: 19763441
[No Abstract] [Full Text] [Related]
3. Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain.
Ma L; Uchida H; Nagai J; Inoue M; Aoki J; Ueda H
J Pharmacol Exp Ther; 2010 May; 333(2):540-6. PubMed ID: 20123931
[TBL] [Abstract][Full Text] [Related]
4. High-fat diet, obesity and prostate disease: the ATX-LPA axis?
Kulkarni P; Getzenberg RH
Nat Clin Pract Urol; 2009 Mar; 6(3):128-31. PubMed ID: 19204739
[No Abstract] [Full Text] [Related]
5. Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases.
Gendaszewska-Darmach E
Acta Biochim Pol; 2008; 55(2):227-40. PubMed ID: 18560605
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression.
Panupinthu N; Lee HY; Mills GB
Br J Cancer; 2010 Mar; 102(6):941-6. PubMed ID: 20234370
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid signaling: how a small lipid does big things.
Luquain C; Sciorra VA; Morris AJ
Trends Biochem Sci; 2003 Jul; 28(7):377-83. PubMed ID: 12878005
[No Abstract] [Full Text] [Related]
8. Lysophosphatidic acid, LPA: a bad boy becomes good.
Budnik LT
Reprod Biol Endocrinol; 2003 Apr; 1():37. PubMed ID: 12740030
[No Abstract] [Full Text] [Related]
9. [Secretion and role of autotaxin and lysophosphatidic acid in adipose tissue].
Saulnier-Blache JS
J Soc Biol; 2006; 200(1):77-81. PubMed ID: 17144165
[TBL] [Abstract][Full Text] [Related]
10. Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia.
Khurana S; Tomar A; George SP; Wang Y; Siddiqui MR; Guo H; Tigyi G; Mathew S
Exp Cell Res; 2008 Feb; 314(3):530-42. PubMed ID: 18054784
[TBL] [Abstract][Full Text] [Related]
11. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs.
Kanda H; Newton R; Klein R; Morita Y; Gunn MD; Rosen SD
Nat Immunol; 2008 Apr; 9(4):415-23. PubMed ID: 18327261
[TBL] [Abstract][Full Text] [Related]
12. Autotaxin.
Boutin JA; Ferry G
Cell Mol Life Sci; 2009 Sep; 66(18):3009-21. PubMed ID: 19506801
[TBL] [Abstract][Full Text] [Related]
13. Role of lysophosphatidic acid in the regulation of uterine leiomyoma cell proliferation by phospholipase D and autotaxin.
Billon-Denis E; Tanfin Z; Robin P
J Lipid Res; 2008 Feb; 49(2):295-307. PubMed ID: 18024704
[TBL] [Abstract][Full Text] [Related]
14. Autotaxin delays apoptosis induced by carboplatin in ovarian cancer cells.
Vidot S; Witham J; Agarwal R; Greenhough S; Bamrah HS; Tigyi GJ; Kaye SB; Richardson A
Cell Signal; 2010 Jun; 22(6):926-35. PubMed ID: 20100569
[TBL] [Abstract][Full Text] [Related]
15. Determination of phospholipase D, lysophospholipase D and DG kinase signaling pathways in disease states by mass spectrometry.
Wakelam MJ; Powner DJ; Pettitt TR
Adv Enzyme Regul; 2008; 48():254-60. PubMed ID: 18364243
[No Abstract] [Full Text] [Related]
16. Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain.
Inoue M; Ma L; Aoki J; Ueda H
J Neurochem; 2008 Dec; 107(6):1556-65. PubMed ID: 19014389
[TBL] [Abstract][Full Text] [Related]
17. Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis.
Samadi N; Gaetano C; Goping IS; Brindley DN
Oncogene; 2009 Feb; 28(7):1028-39. PubMed ID: 19079345
[TBL] [Abstract][Full Text] [Related]
18. The ins and outs of lysophosphatidic acid signaling.
Moolenaar WH; van Meeteren LA; Giepmans BN
Bioessays; 2004 Aug; 26(8):870-81. PubMed ID: 15273989
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine 1-phosphate: a potential molecular target for ovarian cancer therapy?
Dai L; Xia P; Di W
Cancer Invest; 2014 Mar; 32(3):71-80. PubMed ID: 24499107
[TBL] [Abstract][Full Text] [Related]
20. Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.
Valdés-Rives SA; González-Arenas A
Mediators Inflamm; 2017; 2017():9173090. PubMed ID: 29430083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]